Applied Precision Hopes to Raise $50M in IPO; Cash to Help Grow Nascent High-Content Arm | GenomeWeb

Applied Precision, which counts among its businesses a small high-content cellular analysis arm, hopes to raise approximately $50 million in an initial public offering, according to a registration statement filed with the US Securities and Exchange Commission this week.

Based in the Seattle suburb of Issaquah, Applied Precision broadly sells automated metrology, inspection, imaging, and analysis equipment for the semiconductor and life sciences industries.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.